NCT01887418View on ClinicalTrials.gov

Pharmacokinetic Study of Testosterone Enanthate

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Hypogonadism
Interventions
DRUG

QuickShot™ - 50 mg Treatment B

QuickShot™ for the delivery of testosterone

DRUG

QuickShot™ - 100 mg Treatment A

QuickShot™ for the delivery of testosterone

DRUG

Delatestryl 200 mg IM Treatment C

Standard of care

Trial Locations (1)

02445

Mens Health Boston, Brookline

Sponsors
All Listed Sponsors
lead

Antares Pharma Inc.

INDUSTRY

NCT01887418 - Pharmacokinetic Study of Testosterone Enanthate | Biotech Hunter | Biotech Hunter